Sangamo Therapeutics Inc (SGMO) stock news · rev $39.6M
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
This SGMO news page leads with what Sangamo Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for SGMO yet. We will not pad this page with generic market recap.
Latest reported SGMO revenue for 2025-12-31 was $39.6M. Net income was -$122.9M. Revenue was down 31.6% from 2024-12-31 to 2025-12-31. SGMO currently screens at market cap $74.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SGMO stock page; for the tape open the quote page.
SGMO stock news FAQ
What are SGMO's latest revenue and net income?
Latest cached Sangamo Therapeutics Inc (SGMO) revenue for Dec 31, 2025 was $39.6M. Net income was -$122.9M. Statements: https://lician.com/financials/sgmo
How did SGMO revenue change from the prior cached period?
Cached Sangamo Therapeutics Inc (SGMO) revenue was down 31.6% from $57.8M (Dec 31, 2024) to $39.6M (Dec 31, 2025). Statements: https://lician.com/financials/sgmo
What is SGMO's market cap?
Sangamo Therapeutics Inc (SGMO) market cap is $74.6M on the latest cached fundamentals snapshot.
What kind of company is SGMO?
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Where is SGMO stock news listed?
Cached stock news for Sangamo Therapeutics Inc (SGMO) is listed at https://lician.com/news/sgmo. Filings: https://lician.com/sec/sgmo
Not investment advice.